Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/2010
12/15/2010CN101918426A 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/15/2010CN101918366A Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
12/15/2010CN101918352A Inhibitors of 17beta-hydroxysteroid dehydrogenase
12/15/2010CN101912617A Application of MG53 gene to treatment of insulin resistance, type II diabetes mellitus and related diseases thereof
12/15/2010CN101912487A Medicament for treating neuroendocrine disturbance, sexual function decline and skin aging
12/15/2010CN101912380A Compounds for the treatment of metabolic disorders
12/15/2010CN101090901B Hexahydropyridoisoqinolines as DPP-IV inhibitors
12/15/2010CN101006999B Therapeutic uses and compositions of isoflavones
12/14/2010CA2420292C Contraception process and administration form for the same
12/14/2010CA2252560C Treatment of partial growth hormone insensitivity syndrome
12/09/2010WO2010140401A1 Microneedle array using porous substrate and process for producing same
12/09/2010US20100311775 Novel sEH Inhibitors and Their Use
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100311706 Method of treatment of allergic rhinitis
12/09/2010US20100311702 19-nor-steroid derivatives with a 15alpha, 16alpha-methylene group and a saturated 17, 17-spiro-lactone ring, use thereof, and medicaments containing said derivatives
12/09/2010US20100311673 Sulfanyl-tetrahydropyran-based compounds and methods of their use
12/09/2010US20100311649 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
12/09/2010US20100311648 Melanocortin receptor-specific peptides
12/09/2010US20100311647 Use of melanocortins to treat insulin sensitivity
12/09/2010US20100311644 Isozyme-specific antagonists of protein kinase c
12/09/2010US20100310649 Solid lipid microcapsules containing growth hormone inner core microparticles
12/09/2010US20100310610 Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
12/09/2010US20100310525 Wnt pathway stimulation in reprogramming somatic cells
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258375A1 17B-alkyl-17alpha-oxy-estratrienes
12/08/2010EP2258365A1 Use of organic compounds for immunopotentiation
12/08/2010EP2038294B1 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1455821B1 Parathyroid hormone antibodies and related methods
12/08/2010EP0916345B1 Human growth hormone for treating anorexia nervosa
12/08/2010CN1984644B Stabilised supersaturated solid solutions of steroidal drugs
12/08/2010CN1946382B Rapid dissolution formulation of a calcium receptor-active compound
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN101910192A 19-nor-steroid derivatives with a 15alpha,16alpha-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives
12/08/2010CN101910191A 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid gamma-lactone derivative, use thereof, and medicament containing said derivative
12/08/2010CN101910190A 17-hydroxy-19-nor-21-carboxylic acid-steroid gamma-lactone derivative, use thereof, and medicament containing the derivative
12/08/2010CN101910162A Cyclic pyridyl-N-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
12/08/2010CN101909604A Method of treating dysglycemia and glucose excursions
12/08/2010CN101906128A Estrone compound, as well as preparation method and application thereof
12/08/2010CN101906076A Naphthaline amide derivative serving as protein kinase inhibitor and histone deacetylase inhibitor and preparation method and application thereof
12/08/2010CN101212971B 4-phenyl-5-0x0-l,4,5,6,7,8-hexahydr0quin0line derivatives as medicaments for the treatment of infertility
12/07/2010US7847014 Suitable for producing active substance-containing pressure sensitive adhesive layers or adhesive matrices for active substance release in the field of human or veterinary medicine, e.g. as components of transdermal therapeutic systems
12/07/2010US7846966 treating an estrogen-receptor related condition such as benign prostate hypertrophy or a menopausal complaints, comprising administering 4-benzyl-2-phenylchroman's such as 4-benzyl-3-methyl-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-6-ol, having surprisingly high estrogen receptor affinity
12/07/2010US7846957 Aromatase inhibition to enhance assisted reproduction
12/07/2010US7846924 Cyanopyrroles
12/07/2010US7846916 Steroid on carrier containing pressure sensitive adhesive
12/07/2010CA2488334C 24-sulfoximine vitamin d3 compounds
12/07/2010CA2472309C Multiple dose aromatase inhibitor for treating infertility
12/07/2010CA2434203C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
12/07/2010CA2201368C Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies
12/02/2010WO2010136940A1 Novel glucocorticoid receptor agonists
12/02/2010US20100305500 Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
12/02/2010US20100305197 Conditionally Active Ribozymes And Uses Thereof
12/02/2010US20100305105 Phenylsulfoxyoxazole compound inhibitors of urea transporters
12/02/2010US20100305096 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305052 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
12/02/2010US20100303937 Novel composition to increase testosterone levels
12/02/2010US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/2010US20100303799 Treatment of Conditions Related to Shock
12/02/2010CA2760284A1 Novel glucocorticoid receptor agonists
12/01/2010EP1425033B1 Use of hcg and lh in controlled ovarian hyperstimulation
12/01/2010CN1772885B Method of inducing stem cell to differentiate into pancreatic island-like cell and application of pancreatic island-like cell
12/01/2010CN1617703B Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof
12/01/2010CN101903377A 6H-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101898962A Rhein crystal B-type solid matter, preparation method and use
12/01/2010CN101898961A Parietic acid crystal C type solid matter as well as preparation method and application thereof
12/01/2010CN101898960A Rheinic acid crystal type A solid substance and preparation method and application thereof
12/01/2010CN101897927A Medicinal composition for treating hyperthyroidism and preparation method thereof
12/01/2010CN101897906A Traditional Chinese medicine for treating hyperthyroidism
12/01/2010CN101897891A Chinese medicinal powder for treating cecidium
12/01/2010CN101897776A New application of Chinese flowing crabapple extractive and phlorizin
12/01/2010CN101897687A New application of sodium valproate in treating liver inflammation related disease
12/01/2010CN101066126B Health food suitable for middle aged and old women
12/01/2010CN101011100B Ice cream powder
11/2010
11/30/2010US7842825 Using 3-(3-chlorobiphenyl-4-oxymethyl)benzoic acid; antidiabetic agents; type 2 diabetes; insulin resistance; impaired glucose tolerance
11/30/2010US7842706 Pharmaceutical composition
11/30/2010CA2326653C Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
11/25/2010US20100298411 Lipid-modified double-stranded rna having potent rna interference effect
11/25/2010US20100298393 Modulation of Growth Hormone, DHEA, and Cortisol with Positive Modulators of AMPA Type Glutamate Receptors
11/25/2010US20100298347 Substituted 2-naphthoic acids as antagonists of gpr105 activity
11/25/2010US20100298316 Benzothiazoles Having Histamine H3 Receptor Activity
11/25/2010US20100298236 Soluble gp130 muteins with improved binding activity
11/25/2010US20100298201 Peptidomimetic macrocycles with improved properties
11/25/2010US20100297249 Enhancement of the efficacy of therapeutic proteins
11/25/2010US20100297230 Compositions and methods for prostate and menstrual/menopausal related health
11/25/2010US20100297032 Transdermal delivery system
11/24/2010EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody
11/24/2010EP2253630A1 Heterocyclic compound and use thereof
11/24/2010EP2252301A1 Use of ulipristal for treating uterine fibroids
11/24/2010EP1545621B1 Pharmaceutical compositions comprising complexes of phosphate derivatives of lipophilic compounds
11/24/2010EP1298439B1 Method for screening mch receptor antagonist/agonist
11/24/2010CN101892262A Construction and application of IRES (Internal Ribosome Entry Site) mediated four GH (Growth Hormone) subtypes and IGF-I (Insulin-like Growth Factor-I) bicistronic eukaryon co-expression vector
11/24/2010CN101891738A Dasatinib polymorph and preparation method and medical composite thereof
11/24/2010CN101891680A Modulators of atp-binding cassette transporters
11/24/2010CN101890166A Combination of organic compounds
11/24/2010CN101890125A Medicament for treating hyperthyroidism and preparation method thereof
11/23/2010US7838595 high purity; storage stability; electrophilically activated polymer derivatives with aldehyde functionality for conjugating to biologically active molecules; drug-polymer conjugate;
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 290